Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 June 2025 | Story Onthatile Tikoe | Photo Kaleidoscope Studios
Prof Hester C. Klopper
Prof Hester C. Klopper, Vice-Chancellor and Principal of the UFS, will facilitate the UFS Thought-Leader Series discussion titled Reimagining Higher Education for Employability and Sustainability.

The University of the Free State (UFS) is proud to announce the next instalment of its prestigious Thought-Leader Series, titled Reimagining Higher Education for Employability and Sustainability. This highly anticipated event – held in collaboration with the Free State Arts Festival - will take place on Thursday, 17 July 2025, from 12:00 to 14:00 at the Albert Wessels Auditorium, UFS Bloemfontein Campus. Attendance is free and open to the public. 

Now in its seventh year, the UFS Thought-Leader Series has established itself as a dynamic platform for robust public dialogue on pressing local and global issues. The series brings together influential voices from academia, industry, and civil society, reflecting the university’s continued commitment to thought leadership, public engagement, and transformative impact.

 

Rethinking the purpose of Higher Education

This year’s theme comes at a critical time. South Africa faces escalating youth unemployment, rapid technological change, and the complexities of a shifting global economy. Against this backdrop, questions around the purpose of higher education and its alignment with employability and sustainability have become increasingly urgent. 

The panel will explore how universities can better integrate their teaching, research, and community engagement to address the real-world needs of graduates and society at large. 

Prof Hester C. Klopper, Vice-Chancellor and Principal of the UFS, will serve as the facilitator. With her extensive leadership experience and academic expertise, she is well-positioned to guide what promises to be an insightful and forward-thinking conversation. 

 

Meet the panellists 

The session will feature an esteemed panel of thought leaders from the higher education landscape: 

 

Dr Max Price

Former Vice-Chancellor of the University of Cape Town, Dr Max Price brings deep insights into leadership during transformative moments in South African higher education. A medical doctor and Rhodes Scholar, he holds postgraduate qualifications in public health. His recent memoir, Statues and Storms: Leading through change, reflects on steering a university through turbulent times and fostering dialogue on contested transformation issues. 

 

Dr Phethiwe Matutu

As CEO of Universities South Africa (USAf), Dr Phethiwe Matutu leads national initiatives shaping the future of higher education. A mathematician by training, she has held strategic leadership roles at the National Research Foundation and the Department of Science and Technology. Her work is rooted in advancing equity, innovation, and access within the post-school education system. 

 

Prof Paul E Green

Deputy Vice-Chancellor: Teaching and Learning at Sol Plaatje University, Prof Paul E Green is a specialist in systems thinking and higher education quality. Holding a PhD from the University of KwaZulu-Natal, he has served in senior academic positions across several institutions. His research centres on integrating education, innovation, and community impact to meet contemporary challenges. 

 

Prof Pamela Dube 

Prof Pamela Dube is the Vice-Chancellor and Principal of the Central University of Technology (CUT) - the first woman to be appointed to this role in the Free State. A distinguished academic and visionary leader with extensive global experience, she has served in senior positions across several universities and national institutions. Her work spans a wide range of fields, including student development, postcolonial studies, gender equity, and the evolving interface between technology and humanity. Known for her commitment to inclusive transformative education, Prof Dube has received numerous awards and international recognition for her contributions to higher education and leadership.

 

Event Details

Venue: Albert Wessels Auditorium, UFS Bloemfontein Campus
Date: Thursday, 17 July 2025
Time: 12:00–14:00 (90 minutes)

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept